Literature DB >> 6624193

Liposomal chemotherapy in visceral leishmaniasis: an ultrastructural study of an intracellular pathway.

J S Weldon, J F Munnell, W L Hanson, C R Alving.   

Abstract

The intracellular fate of liposomes administered intracardially was examined in the liver and spleen of hamsters experimentally infected with Leishmania donovani. Separate groups of animals were treated with liposomes containing either an antileishmanial agent, a colloidal gold marker, or saline. Ultrastructural examinations of lysosomal interactions with the parasitophorous vacuole and with phagocytized liposomes were made. Lysosomes readily fused with the parasitophorous vacuoles but appeared to have little effect on the parasite, possibly due to the production of enzyme inhibitors. Liposomes rapidly became localized in lysosomes subsequent to endocytosis by macrophages. Morphologic evidence suggested that secondary lysosomes containing liposomal residues then fused with the parasitophorous vacuole. Aspects of one possible pathway are discussed which may account for the greatly enhanced effectiveness of liposomal chemotherapy for experimental visceral leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6624193     DOI: 10.1007/bf00927697

Source DB:  PubMed          Journal:  Z Parasitenkd        ISSN: 0044-3255


  20 in total

1.  Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases.

Authors:  A A Mahmoud; K S Warren
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

2.  Antileishmanial activity of antimonials entrapped in liposomes.

Authors:  R R New; M L Chance; S C Thomas; W Peters
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

3.  The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.

Authors:  C D Black; G J Watson; R J Ward
Journal:  Trans R Soc Trop Med Hyg       Date:  1977       Impact factor: 2.184

4.  Morphological observations on the cellular and subcellular destination of intravenously administered liposomes.

Authors:  A W Segal; E J Wills; J E Richmond; G Slavin; C D Black; G Gregoriadis
Journal:  Br J Exp Pathol       Date:  1974-08

5.  A low-viscosity epoxy resin embedding medium for electron microscopy.

Authors:  A R Spurr
Journal:  J Ultrastruct Res       Date:  1969-01

6.  Fate of phospholipids in liposomal model membranes damaged by antibody and complement.

Authors:  K Inoue; S C Kinsky
Journal:  Biochemistry       Date:  1970-11-24       Impact factor: 3.162

7.  Action of pure phospholipase A 2 and phospholipase C on human erythrocytes and ghosts.

Authors:  B Roelofsen; R F Zwaal; P Comfurius; C B Woodward; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1971-09-14

8.  The resistance of intracellular Leishmania parasites to digestion by lysosomal enzymes.

Authors:  D H Lewis; W Peters
Journal:  Ann Trop Med Parasitol       Date:  1977-09

9.  Liposomes containing chelating agents. Cellular penetration and a possible mechanism of metal removal.

Authors:  Y E Rahman; B J Wright
Journal:  J Cell Biol       Date:  1975-04       Impact factor: 10.539

10.  Leishmania donovani. Hamster macrophage interactions in vitro: cell entry, intracellular survival, and multiplication of amastigotes.

Authors:  K P Chang; D M Dwyer
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs.

Authors:  O Kayser; C Olbrich; S L Croft; A F Kiderlen
Journal:  Parasitol Res       Date:  2002-12-11       Impact factor: 2.289

Review 2.  Liposomes as carriers of antimicrobial agents.

Authors:  G Lopez-Berestein
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

3.  In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomes.

Authors:  H Tachibana; E Yoshihara; Y Kaneda; T Nakae
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

4.  Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice.

Authors:  M H Cynamon; C E Swenson; G S Palmer; R S Ginsberg
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 5.  Liposomes in treatment of infectious diseases.

Authors:  F Emmen; G Storm
Journal:  Pharm Weekbl Sci       Date:  1987-06-19

6.  Intracellular visualization of ampicillin-loaded nanoparticles in peritoneal macrophages infected in vitro with Salmonella typhimurium.

Authors:  H Pinto-Alphandary; O Balland; M Laurent; A Andremont; F Puisieux; P Couvreur
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.